Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...
A woman with SMA type 3 became pregnant while on Spinraza treatment and gave birth to a healthy child, per a case report.
We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any therapeutics to target the root cause of geographic atrophy, an advanced form of dry AMD ...
Geographic atrophy (GA) can be visually confusing. People often tell me that one minute they see something, and the next minute they don’t. For example, the word you’re reading might be “she ...
ANX005 First Potential Targeted Therapy for Guillain-Barré Syndrome Advancing Towards 1H 2025 BLA Submission ANX007 First Potential Neuroprotective Therapy for Geographic Atrophy Expected to Complete ...
compared to other treatments on the market. These include Biogen’s once-quarterly IT administration of Spinraza (nusinersen) and Roche’s once-daily Evrysdi (risdiplam). Considering the growing market ...
The most common areas of injury are the thigh, followed by the arm. Almost all muscle contusions can be treated without surgery, but there is often debate about what the ideal treatment of a muscle ...
Retinal layer thinning in Multiple Sclerosis (MS) associates with clinical disability, brain atrophy, and neurodegeneration, functioning as a potential biomarker for disease progression and treatment ...
a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration with global eye health ...
Aviceda Therapeutics secured $207.5 million in Series C funding to support AVD-104 trials for geographic atrophy. The phase 2b/3 study will compare AVD-104's safety ... 2 Part 2 of the phase 2b study ...
Learn more Browsing the topical pain relief aisles can be overwhelming. When choosing the best muscle rub to help manage your pain, you want to look for quick but long-lasting relief and a clear ...
Credit: Diana Shechtman, OD Sherrol A. Reynolds, OD, FAAO, FNAP, identifies patients who are most at risk for geographic atrophy and provides clinicians with guidance for managing the ...